Clinical TrialsBinge Eating Clinical Trials 2022
Reviewed by Michael Gill, B. Sc.
Image of Drexel University, Stratton Hall in Philadelphia, United States.
Phase-Based Progress Estimates
1
Effectiveness
1
Safety

MABT: Mindful Awarenessfor Bulimia Nervosa

18+
All Sexes
This trial is designed to study the independent and combined effects of four components of mindfulness-based behavioral therapy on eating pathology. The four components are Mindful Awareness, Distress Tolerance, Emotion Modulation, and Values-Based Decision Making. The trial will compare the efficacy of each component when used alone and in combination with standard behavioral treatment for bulimia nervosa and binge eating disorder. The primary aim of the study is to evaluate the independent efficacy of each treatment component on eating pathology. Secondary aims are to test the hypotheses that the efficacy of each component is moderated by related baseline deficits in self-regulation, and to quantify the component interaction
Recruiting
Has No Placebo
Drexel University, Stratton Hall
Image of Regional Centre for the Treatment of Eating Disorders in Ottawa, Canada.
Phase-Based Progress Estimates
1
Effectiveness
1
Safety

Unguided Self-Help, GPIPfor Binge Eating Disorder (BED)

18+
All Sexes
Binge Eating Disorder (BED) affects as many as 3% of women and men in Ontario, 8% of obese individuals, and 30% to 50% of those participating in weight loss programs. BED, the most common eating disorder, is characterized by over-eating with loss of control (i.e., binge eating), but with no purging (e.g., vomiting).Our previous research indicates that the total health care costs for women with BED is 36% higher than the Canadian average for women of a similar age, and that health care costs significantly decreased following intensive treatment at our Centre. The main goal of our study is to inform the development of a stepped care approach to the treatment of BED. Stepped care involves providing easily accessible low intensity treatment first, and then providing more expensive intensive treatment second, if necessary. The second goal is to assess if a second more intensive step of treatment provides added value. Although stepped care for BED is suggested by a number of clinicians and researchers, no study adequately tests predictors of who might benefit from minimal treatment alone and who would require the more intensive second step. The results of this study will guide decision making regarding who benefits from stepped care, and will help to increase the accessibility, availability, and cost effectiveness of psychological treatments for BED.
Waitlist Available
Has No Placebo
Regional Centre for the Treatment of Eating DisordersGeorge A Tasca, Ph.D,C.Psych
24 Binge Eating Clinical Trials Near Me
Top Hospitals for Binge Eating Clinical Trials
Image of Drexel University, Stratton Hall in Pennsylvania.
Drexel University, Stratton Hall
Philadelphia
3Active Trials
5All Time Trials for Binge Eating
2018First Binge Eating Trial
Top Cities for Binge Eating Clinical Trials
Binge Eating Clinical Trials by Phase of Trial
Phase 2 Binge Eating Clinical Trials
1Active Binge Eating Clinical Trials
1Number of Unique Treatments
1Number of Active Locations
Psychotherapy
Binge Eating Clinical Trials by Age Group
< 18 Binge Eating Clinical Trials
1Active Binge Eating Clinical Trials
Cognitive-Behavioral Therapy for Adolescent Binge/Loss-of-Control Eating
Most Recent Binge Eating Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Cognitive Behavioral Therapy (CBT) for Bulimia Nervosa
4/22/2022
N/A
Psychotherapy for Hyperphagia
3/16/2022
Phase 2
Cognitive behavioral therapy guided self help (CBTgsh) for Eating, Binge
2/15/2022
N/A
Solriamfetol for Eating Disorders
6/15/2021
Phase 4
Intervention component: Decrease unhealthy weight control practices for Eating, Binge
2/16/2021
N/A
Top Treatments for Binge Eating Clinical Trials
Treatment Name
Active Binge Eating Clinical Trials
All Time Trials for Binge Eating
First Recorded Binge Eating Trial
LDX
2
2
2019
NB medication (Naltrexone Bupropion combination)
2
2
2017
Behavioral Therapy for Eating Disorders
1
2
2020
Cognitive Behavioral Therapy (CBT)
1
4
1994
Cognitive behavioral therapy guided self help (CBTgsh)
1
1
2022
Recently Completed Studies with FDA Approved Treatments for Binge Eating
Treatment
Year
Sponsor
ACT-539313
2021
Idorsia Pharmaceuticals Ltd.

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 11th, 2021

Last Reviewed: November 15th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Relevant Clinical Trials

Hemochromatosis Clinical Trials 2022
Gastric Bypass Clinical Trials 2022
Hairy Cell Leukemia Clinical Trials 2022
Kidney Transplant Clinical Trials 2022
Heart Disease Clinical Trials 2022
Wet Macular Degeneration Clinical Trials 2022
Hiv Aids Clinical Trials 2022
Hernia Clinical Trials 2022
Malignant Melanoma Clinical Trials 2022
Chordoma Clinical Trials 2022
Osteogenesis Imperfecta Clinical Trials 2022
Parkinsons Disease Clinical Trials 2022
Primary Biliary Cirrhosis Clinical Trials 2022
Anosmia Clinical Trials 2022
Social Anxiety Clinical Trials 2022
Polio Clinical Trials 2022
Lichen Planus Clinical Trials 2022
Plaque Psoriasis Clinical Trials 2022
Pre Diabetes Clinical Trials 2022
PAD Clinical Trials 2022

Top Oncology Trials

Cancer Clinical Trials 2022
Pancreas Cancer Clinical Trials 2022
Prostate Cancer Clinical Trials 2022
Pancreatic Cancer Clinical Trials 2022
Oncology Clinical Trials 2022
Breast Cancer Clinical Trials 2022
Melanoma Clinical Trials 2022
Multiple Myeloma Clinical Trials 2022
Triple Negative Breast Cancer Clinical Trials 2022
Ovarian Cancer Clinical Trials 2022
Colon Cancer Clinical Trials 2022
Lung Cancer Clinical Trials 2022
CLL Clinical Trials 2022
Small Cell Lung Cancer Clinical Trials 2022
Esophageal Cancer Clinical Trials 2022
Mesothelioma Clinical Trials 2022
AML Clinical Trials 2022
Leukemia Clinical Trials 2022
Bladder Cancer Clinical Trials 2022
Metastatic Breast Cancer Clinical Trials 2022

Popular Clinical Trials

COVID Clinical Trials 2022
Depression Clinical Trials 2022
ALS Clinical Trials 2022
Coronavirus Clinical Trials 2022
IVF Clinical Trials 2022
Marijuana Clinical Trials 2022
Type 1 Diabetes Clinical Trials 2022
Tinnitus Clinical Trials 2022
PTSD Clinical Trials 2022
Diabetes Clinical Trials 2022
Lupus Clinical Trials 2022
Rheumatoid Arthritis Clinical Trials 2022
Psoriasis Clinical Trials 2022
Multiple Sclerosis Clinical Trials 2022
Obesity Clinical Trials 2022
Psilocybin Clinical Trials 2022
Osteoarthritis Clinical Trials 2022
Lyme Disease Clinical Trials 2022
Retinitis Pigmentosa Clinical Trials 2022
Smoking Clinical Trials 2022
References1 Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. https://pubmed.ncbi.nlm.nih.gov/115569412 Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001 Jul;2(4):297-307. https://pubmed.ncbi.nlm.nih.gov/114382463 Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985 Sep;10(3):141-6. https://pubmed.ncbi.nlm.nih.gov/40532614 Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction. 1993 Jun;88(6):791-804. https://pubmed.ncbi.nlm.nih.gov/83299705 Fairburn CG, Beglin SJ. Assessment of eating disorders: interview or self-report questionnaire? Int J Eat Disord. 1994 Dec;16(4):363-70. https://pubmed.ncbi.nlm.nih.gov/78664156 Hudson JI, Hiripi E, Pope HG Jr, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007 Feb 1;61(3):348-58. Epub 2006 Jul 3. Erratum in: Biol Psychiatry. 2012 Jul 15;72(2):164. https://pubmed.ncbi.nlm.nih.gov/168153227 Forbush KT, Wildes JE, Pollack LO, Dunbar D, Luo J, Patterson K, Petruzzi L, Pollpeter M, Miller H, Stone A, Bright A, Watson D. Development and validation of the Eating Pathology Symptoms Inventory (EPSI). Psychol Assess. 2013 Sep;25(3):859-78. doi: 10.1037/a0032639. Epub 2013 Jul 1. https://pubmed.ncbi.nlm.nih.gov/238151168 Arcelus J, Mitchell AJ, Wales J, Nielsen S. Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies. Arch Gen Psychiatry. 2011 Jul;68(7):724-31. doi: 10.1001/archgenpsychiatry.2011.74. https://pubmed.ncbi.nlm.nih.gov/217272559 Latner JD, Mond JM, Kelly MC, Haynes SN, Hay PJ. The Loss of Control Over Eating Scale: development and psychometric evaluation. Int J Eat Disord. 2014 Sep;47(6):647-59. doi: 10.1002/eat.22296. Epub 2014 May 26. https://pubmed.ncbi.nlm.nih.gov/2486235110 Boutelle KN, Zucker NL, Peterson CB, Rydell SA, Cafri G, Harnack L. Two novel treatments to reduce overeating in overweight children: a randomized controlled trial. J Consult Clin Psychol. 2011 Dec;79(6):759-71. doi: 10.1037/a0025713. https://pubmed.ncbi.nlm.nih.gov/22122291
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top